Price Alert

Kezar Life Sciences Inc. (KZR)

NASDAQ: KZR · Real-Time Price · USD

4.10

0.28 (7.33%)

At close: Sep 05, 2025, 3:59 PM

3.85

-6.03%

After-hours: Sep 05, 2025, 06:55 PM EDT

7.33% (1D)

Bid	3.77
Market Cap	30M
Revenue (ttm)	n/a
Net Income (ttm)	-70.79M
EPS (ttm)	-9.7
PE Ratio (ttm)	-0.42
Forward PE	-0.65
Analyst	Hold

Ask	4.1
Volume	56,474
Avg. Volume (20D)	51,869
Open	3.90
Previous Close	3.82
Day's Range	3.86 - 4.15
52-Week Range	3.62 - 9.20
Beta	0.65

About KZR

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol KZR

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for KZR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

11 months ago

+42.1%

Kezar Life Sciences shares are trading higher afte... Unlock content with Pro Subscription

News

3 weeks ago · businesswire.com

Kezar Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immun...

1 month ago · businesswire.com

Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold on PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis